Optic Nerve Glioma
Also known as: Optic Glioma / Optic nerve glioma (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00853 | Temozolomide | 0 | Withdrawn | 1 |
| DB00112 | Bevacizumab | 1 / 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 1 / 2 | Recruiting | 1 |
| DB00762 | Irinotecan | 1 / 2 | Recruiting | 1 |
| DB00643 | Mebendazole | 1 / 2 | Recruiting | 1 |
| DB11689 | Selumetinib | 1 / 2 | Completed | 1 |
| DB11689 | Selumetinib | 1 / 2 | Recruiting | 1 |
| DB00853 | Temozolomide | 1 / 2 | Recruiting | 1 |
| DB00541 | Vincristine | 1 / 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB00997 | Doxorubicin | 2 | Recruiting | 1 |
| DB06423 | Endostatin | 2 | Recruiting | 1 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB15127 | Hydrogen | 2 | Completed | 1 |
| DB11689 | Selumetinib | 2 | Completed | 1 |
| DB14546 | Sulfate ion | 2 | Completed | 1 |
| DB00541 | Vincristine | 2 | Recruiting | 1 |
| DB00853 | Temozolomide | 3 | Withdrawn | 1 |